Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome

Background: Metabolic syndrome is defined as a cluster of metabolic disorders, including hypertension, insulin resistance, dyslipidemia, diabetes, cardiovascular disease and abdominal [central] obesity. It is also found under different names, such as syndrome X, “deadly quartet” and insulin resistan...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alaaeldin Eissa, Abdelateef Abdelateef, Hassan Elkotby
Formato:	article
Lenguaje:	EN
Publicado:	Al-Azhar University, Faculty of Medicine (Damietta) 2021
Materias:	curcumin atorvastatin combination therapy metabolic syndrome Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9ac5af370f0a4cea866978f50cc91a0e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9ac5af370f0a4cea866978f50cc91a0e
record_format	dspace
spelling	oai:doaj.org-article:9ac5af370f0a4cea866978f50cc91a0e2021-12-02T17:05:59ZPotential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome2636-41742682-378010.21608/ijma.2021.61857.1267https://doaj.org/article/9ac5af370f0a4cea866978f50cc91a0e2021-07-01T00:00:00Zhttps://ijma.journals.ekb.eg/article_169946_2d2596929ecd9e9b4ba52b689dafa3b0.pdfhttps://doaj.org/toc/2636-4174https://doaj.org/toc/2682-3780Background: Metabolic syndrome is defined as a cluster of metabolic disorders, including hypertension, insulin resistance, dyslipidemia, diabetes, cardiovascular disease and abdominal [central] obesity. It is also found under different names, such as syndrome X, “deadly quartet” and insulin resistance syndrome. The aim of the work: to investigate the potential effect of curcumin and compare it with the effect of metformin and atorvastatin on hepatic and metabolic changes in metabolic syndrome. Materials and Methods: Fifty male Sprague–Dawley [8 weeks old] weighting 150-200 g obtained from animal house of the department of pharmacology, Al-Azhar Faculty of Medicine. Rats were kept in regular dark – light cycle with free access to groups [specific diet and water] that were renewed daily and were observed for water intake, food intake, changes in body weight and abdominal circumference during 16-week study period. Results: Histopathological changes after administration of high carbohydrate high fat [HCHF] diet, revealed fatty changes, ballooning degeneration [vacuoles] and fibrosis. Infiltration by large numbers of inflammatory cells was detected in the portal area and there was an inflammatory reaction dividing the hepatic parenchyma into lobules. On the other side, the treated rats with curcumin showed improved inflammation [few inflammatory cells, slight ballooning and fibrosis, but still present moderate steatosis in liver samples. The atorvastatin group revealed comparable results to the curcumin group. However, when combined together, they were able to restore hepatic tissue to nearly its normal structure. Conclusions: Combination therapy by curcumin and atorvastatin was more effective in the management of non-alcoholic fatty liver/non-alcoholic steatohepatitis [NAFL/NASH]. However, further studies are required to evaluate the applicability of the present results in human beings and to judge the safety and efficacy of curcumin, atorvastatin and their combination.Alaaeldin EissaAbdelateef AbdelateefHassan ElkotbyAl-Azhar University, Faculty of Medicine (Damietta)articlecurcuminatorvastatincombinationtherapymetabolic syndromeMedicine (General)R5-920ENInternational Journal of Medical Arts, Vol 3, Iss 3, Pp 1507-1515 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	curcumin atorvastatin combination therapy metabolic syndrome Medicine (General) R5-920
spellingShingle	curcumin atorvastatin combination therapy metabolic syndrome Medicine (General) R5-920 Alaaeldin Eissa Abdelateef Abdelateef Hassan Elkotby Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome
description	Background: Metabolic syndrome is defined as a cluster of metabolic disorders, including hypertension, insulin resistance, dyslipidemia, diabetes, cardiovascular disease and abdominal [central] obesity. It is also found under different names, such as syndrome X, “deadly quartet” and insulin resistance syndrome. The aim of the work: to investigate the potential effect of curcumin and compare it with the effect of metformin and atorvastatin on hepatic and metabolic changes in metabolic syndrome. Materials and Methods: Fifty male Sprague–Dawley [8 weeks old] weighting 150-200 g obtained from animal house of the department of pharmacology, Al-Azhar Faculty of Medicine. Rats were kept in regular dark – light cycle with free access to groups [specific diet and water] that were renewed daily and were observed for water intake, food intake, changes in body weight and abdominal circumference during 16-week study period. Results: Histopathological changes after administration of high carbohydrate high fat [HCHF] diet, revealed fatty changes, ballooning degeneration [vacuoles] and fibrosis. Infiltration by large numbers of inflammatory cells was detected in the portal area and there was an inflammatory reaction dividing the hepatic parenchyma into lobules. On the other side, the treated rats with curcumin showed improved inflammation [few inflammatory cells, slight ballooning and fibrosis, but still present moderate steatosis in liver samples. The atorvastatin group revealed comparable results to the curcumin group. However, when combined together, they were able to restore hepatic tissue to nearly its normal structure. Conclusions: Combination therapy by curcumin and atorvastatin was more effective in the management of non-alcoholic fatty liver/non-alcoholic steatohepatitis [NAFL/NASH]. However, further studies are required to evaluate the applicability of the present results in human beings and to judge the safety and efficacy of curcumin, atorvastatin and their combination.
format	article
author	Alaaeldin Eissa Abdelateef Abdelateef Hassan Elkotby
author_facet	Alaaeldin Eissa Abdelateef Abdelateef Hassan Elkotby
author_sort	Alaaeldin Eissa
title	Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome
title_short	Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome
title_full	Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome
title_fullStr	Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome
title_full_unstemmed	Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome
title_sort	potential effect of curcumin versus atorvastatin on hepatic and metabolic changes in rat model of metabolic syndrome
publisher	Al-Azhar University, Faculty of Medicine (Damietta)
publishDate	2021
url	https://doaj.org/article/9ac5af370f0a4cea866978f50cc91a0e
work_keys_str_mv	AT alaaeldineissa potentialeffectofcurcuminversusatorvastatinonhepaticandmetabolicchangesinratmodelofmetabolicsyndrome AT abdelateefabdelateef potentialeffectofcurcuminversusatorvastatinonhepaticandmetabolicchangesinratmodelofmetabolicsyndrome AT hassanelkotby potentialeffectofcurcuminversusatorvastatinonhepaticandmetabolicchangesinratmodelofmetabolicsyndrome
_version_	1718381804461752320

Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome

Ejemplares similares